Thomas Wilson, PhD, DrPH and Vince Kuraitis, JD, MBA
The conventional wisdom in the disease management (DM) community has been that the Medicare Health Support (MHS) project would provide the evidence to resolve two issues:
First, MHS would once-and-for-all resolve the issue of “does DM have ROI? (return on investment).” It was thought that the randomized control [...]





Recent Comments